SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Cacaito who wrote (3973)12/21/1997 9:38:00 PM
From: BigKNY3  Read Replies (1) of 23519
 
Cacaito <<BigKNY3, I do share your frustration with the constant tirade of PFE did this or that against Vivus. Pfizer has never attack Vivus in any form but competing with their science>>

Cacaito: I appreciated your comments. PFE probably has very little interest in going after MUSE. Frankly, sales of $200 million would be a major disappointment.

Blaming PFE for VVUS' woes or attacking Viagra is just an indication of investor frustration with VVUS. Over the long-term, I believe VVUSers may very well benefit from the introduction of Viagra.

BigKNY3
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News